Livongo Health (LVGO) Misses Q1 EPS by 2c

Livongo Health (NASDAQ: LVGO) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $68.8 million versus the consensus estimate of $65.83 million.

“Livongo is well positioned to provide assistance to some of the most vulnerable populations during the COVID-19 pandemic - people with chronic conditions - and our remote monitoring, digitally powered and real-time personal coaching capabilities, and access to telehealth services are well suited to track vital signs of interest in maintaining the health of our Members,” said Zane Burke, Chief Executive Officer of Livongo. “The COVID-19 pandemic has accelerated the need for new virtual care delivery models like Livongo. We are pleased to announce our relationship with the Government Employees Health Association, Inc. (GEHA), to provide the Livongo for Diabetes, Hypertension, and Diabetes Prevention solutions for federal employees, retirees, and their dependents that receive GEHA medical coverage.”

GUIDANCE:

Livongo Health sees Q2 2020 revenue of $73-75 million, versus the consensus of $73.66 million.

Livongo Health sees FY2020 revenue of $290-300 million, versus the consensus of $293.98 million.

For earnings history and earnings-related data on Livongo Health (LVGO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79